SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-015054
Filing Date
2014-08-12
Accepted
2014-08-12 10:32:04
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20140630_10q.htm 10-Q 1012154
2 EXHIBIT 3.1 ex3-1.htm EX-3 39609
3 EXHIBIT 31.1 ex31-1.htm EX-31 11746
4 EXHIBIT 31.2 ex31-2.htm EX-31 11643
5 EXHIBIT 32 ex32.htm EX-32 9104
  Complete submission text file 0001437749-14-015054.txt   6010309

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS insy-20140630.xml EX-101.INS 1018545
7 EXHIBIT 101.SCH insy-20140630.xsd EX-101.SCH 39560
8 EXHIBIT 101.CAL insy-20140630_cal.xml EX-101.CAL 34140
9 EXHIBIT 101.DEF insy-20140630_def.xml EX-101.DEF 199020
10 EXHIBIT 101.LAB insy-20140630_lab.xml EX-101.LAB 303969
11 EXHIBIT 101.PRE insy-20140630_pre.xml EX-101.PRE 196107
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 141032804
SIC: 2834 Pharmaceutical Preparations